Preparation method of traditional Chinese medicine for treating phlegm-randomized-stagnation-type hyperlipemia

Abstract

The invention relates to a preparation method of a traditional Chinese medicine for treating phlegm-randomized-stagnation-type hyperlipemia, belonging to the technical field of preparation methods of traditional Chinese medicines. The existing method for treating phlegm-randomized-stagnation-type hyperlipemia generally adopts lipid regulators, and has the defect of great toxic and side effects. The technical scheme is as follows: the preparation method comprises the following steps: taking Semen Oroxyli, hard clam, stephanotis, Dittany Bark, Herba Ajugae, Japanese polygala, bamboo juice, bamboo shavings, bamboo, loquat leaf, fructus momordicae, ladybell root, Adenophora trachelioides Maxim., Rust-coloured crotalaria herb with root, arisaema cum bile, peucedanum root, Trichosanthes kirilowii Maxim, thunberg fritillary bulb, Pumice Stone, sea clam shell, japanese ardisia, dahurian rhododendron leaf, melon seed, Swamp Mahogany Leaf, leaflet loquat, pummelo pee, membrane of hen egg, swallowwort rhizome, Sinapis alba, Perilla frutescens, stemona, Panax japonicus, almond, Caragana sinica Rehd, arisaema cum bile, balloonflower and licorice; and soaking the traditional Chinese medicines in water, decocting with soft fire, and filtering to remove slag to obtain liquor, thereby obtaining the traditional Chinese medicine for treating phlegm-randomized-stagnation-type hyperlipemia. The prepared traditional Chinese medicine has the advantages of small toxic and side effects, short treatment course and high cure rate.

Description

technical field [0001] The invention relates to the technical field of preparation methods of traditional Chinese medicines, in particular to a preparation method of traditional Chinese medicines for treating hyperlipidemia of phlegm-turbidity middle-retention type. Background technique [0002] At present, in the treatment of hyperlipidemia with phlegm and turbidity, blood lipid-regulating drugs are generally used: [0003] 1. Fenofibrate: ①The incidence of adverse reactions is about 2%-15%. Gastrointestinal reactions and insomnia are more common. ②Contraindications: Patients allergic to this product, patients with history of gallbladder disease, patients with cholelithiasis, patients with severe renal insufficiency, hepatic insufficiency, primary biliary cirrhosis or persistent abnormal liver function of unknown cause. ③Use with caution in patients with gallstones, liver insufficiency, and renal insufficiency. ④ During the use of this product, if there is an increase in...

AI Technical Summary

Problems solved by technology

[0007] 5. Fluvastatin: ① The adverse reaction is mild and short-lived dyspepsia

③ This product interferes with the diagnosis: a. Hemoglobin, hematocrit, and white blood cell count may decrease

④ Poor curative effect on homozygous familial hypercholesterolemia

Due to the complete lack of low-density lipoprotein (LDL) receptors in patients with homozygous familial hypercholesterolemia, simvastatin is less effective in these patients

Images